278 related articles for article (PubMed ID: 17165439)
1. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
Cagayan MS; Gacoba MC
J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
[TBL] [Abstract][Full Text] [Related]
2. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
3. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Ghaemmaghami F; Behroozi S; Mousavi A; Ashrafgangooei T; Gilani MM; Behtash N; Ghanbari Z
Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
6. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
7. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
[TBL] [Abstract][Full Text] [Related]
8. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
9. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
11. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
12. Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Braga A; Maestá I; Michelin OC; Delmanto LR; Consonni M; Rudge MV; Belfort P
Gynecol Oncol; 2009 Mar; 112(3):568-71. PubMed ID: 19108876
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
[TBL] [Abstract][Full Text] [Related]
14. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
[TBL] [Abstract][Full Text] [Related]
15. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
16. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
[TBL] [Abstract][Full Text] [Related]
17. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
18. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract][Full Text] [Related]
19. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
20. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
